U Pitt Team to Use Wafergen’s Whole-Genome RT-PCR Platform for Biomarker Studies | GenomeWeb
NEW YORK (GenomeWeb News) — The University of Pittsburgh Medical School will serve as the alpha test site for Wafergen Biosystem’s real-time PCR system, Wafergen said today.
 
Through a research collaboration with a team led by Department of Medicine Chairman Steven Shapiro, the school will use the WaferGen SmartChip Real-Time PCR System in its efforts to identify biomarkers that are therapeutically useful for chronic obstructive pulmonary disease and for lung cancer.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.